Cryoablation is a minimally invasive procedure that uses extreme cold to destroy fibroids. During the procedure, a small probe is inserted into the fibroid, and liquid nitrogen is delivered to the tissue, causing it to freeze and die. Cryoablation is typically performed on an outpatient basis and has a shorter recovery time than traditional surgery.
High-intensity focused ultrasound uses focused Uterine Fibroid Treatment Devices waves to heat and destroy fibroids. During the procedure, a special device is used to deliver ultrasound energy to the fibroids, causing them to shrink and eventually die. HIFU is typically performed on an outpatient basis and has a shorter recovery time than traditional surgery. Microwave ablation uses heat energy to destroy fibroids. During the procedure, a small probe is inserted into the fibroid, and microwave energy is delivered to the tissue, causing it to shrink and eventually die. Microwave ablation is typically performed on an outpatient basis and has a low risk of complications.Uterine Fibroid Treatment Devices can cause heavy menstrual bleeding, pain and other symptoms. The condition is treatable with minimally invasive procedures. During this outpatient procedure, an interventional radiologist uses X-rays to find the arteries that supply the fibroids. Then they inject small particles of polyvinyl alcohol into the arteries to block blood flow to the fibroids. For women who don't want to undergo a surgery, noninvasive fibroid treatments may relieve their symptoms. Medications can ease pain, reduce heavy bleeding and regulate periods. Birth control pills can also help with symptom relief.UFE can destroy fibroids and shrink the blood vessels that feed them, reducing heavy bleeding from. Follow-up studies show that fibroid tumors rarely regrow after this same-day procedure. However, some women in or near menopause may eventually need a hysterectomy as the uterus is weakened by UFE. Some women experience cramping after the procedure. Sedatives and pain killers are administered before, during and after the procedure to alleviate discomfort. Many women with uterine fibroids are not aware of the available treatment options. Several surgical approaches are used to treat uterine fibroids. Hysterectomy, in which the uterus is removed, is one option. This permanently resolves fibroid symptoms and prevents the formation of new ones. However, the procedure is not recommended for women who want to have children in the future. Other surgical options include a hysteroscopic myomectomy and radiofrequency ablation. During laparoscopic fibroid ablation, a doctor uses radiofrequency energy to destroy uterine fibroids and shrink the blood vessels that feed them. This procedure is less invasive than a hysterectomy and can be performed under local anesthesia.
Read More:
Uterine fibroids are common, non-cancerous tumors of the uterus.
It’s estimated that by the age of 35, 40% of Caucasian women and up to 60% of African American women will have uterine fibroids.
Genetics, race, obesity, and higher estrogen levels are all considered risk factors for developing fibroids.
Uterine Fibroid Market Information By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), By Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2027Market ScenarioMarket Research Future (MRFR) speculates that the U.S. uterine fibroid market is likely to garner USD 39,993.2 million, grabbing a CAGR of 3.24% during the forecast period (2016-2022).
Also termed as myomas or leiomyoma, uterine fibroids are non-cancerous growth which causes symptoms like pain in the pelvis and lower back, heavy bleeding during or between the menstrual cycle, and increased menstrual cramps along with the enlargement of the abdomen.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2394 Market Potential and PitfallsUterine fibroids are spreading over the entire U.S. at a rapid pace mainly due to the increased prevalence of uterine fibroids in the African-American race.
The U.S. uterine fibroid market is anticipated to touch high growth figures in the long run mainly due to the surging prevalence of uterine fibroids and the rising number of hysterectomy surgeries every year.
Several treatment options available such as pharmacotherapy, self-help techniques, invasive surgical procedures, and uterine artery embolization are propelling the market growth in the U.S.The introduction of minimally invasive surgeries such as myomectomy and hysterectomy for treating the excruciating pain of uterine fibroids is expected to encourage the market growth.
Such surgeries have reduced the chances of infection, reduced the hospital stay, and, lowered the recovery time, thereby contributing to the growth.
This has resulted in limited treatment options for uterine fibroids.
